A Prescription for Achieving Equitable Access to Antiobesity Medications-Reference-Cited by-同舟云学术

A Prescription for Achieving Equitable Access to Antiobesity Medications

Published:2023-04-21 Issue:4 Volume:4 Page:e230493
ISSN:2689-0186
Container-title:JAMA Health Forum
language:en
Short-container-title:JAMA Health Forum

Author:

Wright Davene R.¹,Guo Jingchuan²,Hernandez Inmaculada³

Affiliation:

1. Department of Population Medicine, Harvard Medical School and Harvard Pilgrim Health Care Institute, Boston, Massachusetts

2. Department of Pharmaceutical Outcomes and Policy, College of Pharmacy, University of Florida, Gainesville

3. Division of Clinical Pharmacy, Skaggs School of Pharmacy and Pharmaceutical Sciences, University of California, San Diego (UCSD)

Abstract

This Viewpoint discusses newer antiobesity medications that hold promise and how uneven access to these medications could exacerbate obesity disparities.

Publisher

American Medical Association (AMA)

Subject

General Earth and Planetary Sciences,General Environmental Science

Link

https://jamanetwork.com/journals/jama-health-forum/articlepdf/2804219/wright_2023_vp_230005_1681850217.63149.pdf

Reference10 articles.

1. Prevalence of obesity among adults, by household income and education—United States, 2011-2014.;Ogden;MMWR Morb Mortal Wkly Rep,2017

2. Managing obesity: scaling the pyramid to success.;Collazo-Clavell;Mayo Clin Proc,2019

3. Effects of low-dose, controlled-release, phentermine plus topiramate combination on weight and associated comorbidities in overweight and obese adults (CONQUER): a randomised, placebo-controlled, phase 3 trial.;Gadde;Lancet,2011

4. The role of decision support systems in attenuating racial biases in healthcare delivery.;Ganju;Manage Sci,2020

5. Impact of real-time benefit tools on patients’ access to medications: a retrospective cohort study.;Bhardwaj;Am J Med,2022

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. One-Year Weight Reduction With Semaglutide or Liraglutide in Clinical Practice;JAMA Network Open;2024-09-13

2. Addressing weight bias in reproductive medicine: a call to revisit body mass index restrictions for in vitro fertilization treatment;Fertility and Sterility;2024-08

3. Discontinuation and Reinitiation of GLP-1 Receptor Agonists Among US Adults with Overweight or Obesity;2024-07-29

4. Economic evaluation of weight loss and transplantation strategies for kidney transplant candidates with obesity;American Journal of Transplantation;2024-07

5. Projected prescription drug expenditures in 2024: Looking ahead to the inflation reduction era;American Journal of Health-System Pharmacy;2024-04-24